1
Clinical Trials associated with Anti-CD33 CAR-T(The Affiliated Hospital of the Chinese Academy of Military Medical Sciences)Treatment of Relapsed and/or Refractory CD33-positive Acute Myeloid Leukemia by Infusions of Allogeneic CART-33
The purpose of this study is to evaluate the safety and efficiency of allogeneic cluster of differentiation 33 (CD33)-directed chimeric antigen receptor modified T cells (CART-33) infusions in patients with relapsed / refractory acute myeloid leukemia (AML).
100 Clinical Results associated with Anti-CD33 CAR-T(The Affiliated Hospital of the Chinese Academy of Military Medical Sciences)
100 Translational Medicine associated with Anti-CD33 CAR-T(The Affiliated Hospital of the Chinese Academy of Military Medical Sciences)
100 Patents (Medical) associated with Anti-CD33 CAR-T(The Affiliated Hospital of the Chinese Academy of Military Medical Sciences)
100 Deals associated with Anti-CD33 CAR-T(The Affiliated Hospital of the Chinese Academy of Military Medical Sciences)